Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Alessi, Joao V
241  Ergebnisse:
Personensuche X
?
1

Activating point mutations in the MET kinase domain represe..:

Pecci, Federica ; Nakazawa, Seshiru ; Ricciuti, Biagio...
Cancer Discovery.  , 2024
Link: https://doi.org/10.1158/..
 
?
2

Three-year overall survival outcomes and correlative analys..:

Ricciuti, Biagio ; Elkrief, Arielle ; Lin, Jessica...
JTO Clinical and Research Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Impact of TMB/PD-L1 expression and pneumonitis on chemoradi..:

Alessi, Joao V. ; Ricciuti, Biagio ; Wang, Xinan...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
4

Advanced non-small-cell lung cancer treated with first-line..:

Nishino, Mizuki ; Wang, Xinan ; Ricciuti, Biagio...
European Radiology.  33 (2023)  10 - p. 7284-7293 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Letter to the Editor: Reply to Zhao, Wu, and Ma:

Alessi, Joao V. ; Elkrief, Arielle ; Ricciuti, Biagio..
Journal of Thoracic Oncology.  18 (2023)  6 - p. e61-e62 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Letter to the Editor: Reply to Kus and Aktas:

Alessi, Joao V. ; Awad, Mark M.
Journal of Thoracic Oncology.  18 (2023)  8 - p. e84-e85 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Clinical and Molecular Features of Long-term Response to Im..:

Thummalapalli, Rohit ; Ricciuti, Biagio ; Bandlamudi, Chaitanya...
Clinical Cancer Research.  29 (2023)  21 - p. 4408-4418 , 2023
Link: https://doi.org/10.1158/..
 
?
8

Multi-institutional analysis of aneuploidy and outcomes to ..:

Alessi, Joao V ; Price, Adam ; Richards, Allison L...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007618 , 2023
Link: https://doi.org/10.1136/..
 
?
9

Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune..:

Alessi, Joao V. ; Wang, Xinan ; Elkrief, Arielle...
Journal of Thoracic Oncology.  18 (2023)  11 - p. 1524-1537 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Clinicopathologic and Genomic Factors Impacting Efficacy of..:

Alessi, Joao V. ; Elkrief, Arielle ; Ricciuti, Biagio...
Journal of Thoracic Oncology.  18 (2023)  6 - p. 731-743 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Outcomes of Combination Platinum-Doublet Chemotherapy and A..:

Elkrief, Arielle ; Ricciuti, Biagio ; Alessi, Joao V...
The Oncologist.  28 (2023)  11 - p. 978-985 , 2023
Link: https://doi.org/10.1093/..
 
?
12

Loss of p53 and mutational heterogeneity drives immune resi..:

Zhu, Mingrui ; Kim, Jiwoong ; Deng, Qing...
Cancer Cell.  41 (2023)  10 - p. 1731-1748.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Prognostic effect of body mass index in patients with advan..:

Cortellini, Alessio ; Ricciuti, Biagio ; Vaz, Victor R...
Journal for ImmunoTherapy of Cancer.  10 (2022)  2 - p. e004374 , 2022
Link: https://doi.org/10.1136/..
 
?
14

Genomic and biological study of fusion genes as resistance ..:

Kobayashi, Yoshihisa ; Oxnard, Geoffrey R. ; Cohen, Elizabeth F....
Nature Communications.  13 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
15

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibitio..:

Ricciuti, Biagio ; Arbour, Kathryn C. ; Lin, Jessica J....
Journal of Thoracic Oncology.  17 (2022)  3 - p. 399-410 , 2022
Link: https://doi.org/10.1016/..
 
1-15